Integra Lifesciences Holdings Corp (IART)
28.50
+0.38
(+1.35%)
USD |
NASDAQ |
May 23, 16:00
28.50
0.00 (0.00%)
After-Hours: 16:14
Integra Lifesciences Holdings Free Cash Flow: 60.93M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 60.93M |
December 31, 2023 | 73.09M |
September 30, 2023 | 109.75M |
June 30, 2023 | 155.22M |
March 31, 2023 | 199.56M |
December 31, 2022 | 217.38M |
September 30, 2022 | 188.30M |
June 30, 2022 | 204.63M |
March 31, 2022 | 232.22M |
December 31, 2021 | 264.35M |
September 30, 2021 | 274.39M |
June 30, 2021 | 261.81M |
March 31, 2021 | 203.05M |
December 31, 2020 | 139.94M |
September 30, 2020 | 155.10M |
June 30, 2020 | 77.84M |
March 31, 2020 | 82.80M |
December 31, 2019 | 96.90M |
September 30, 2019 | 46.91M |
June 30, 2019 | 123.84M |
March 31, 2019 | 109.20M |
December 31, 2018 | 121.94M |
September 30, 2018 | 102.79M |
June 30, 2018 | 77.66M |
March 31, 2018 | 77.49M |
Date | Value |
---|---|
December 31, 2017 | 71.04M |
September 30, 2017 | 58.53M |
June 30, 2017 | 60.87M |
March 31, 2017 | 74.63M |
December 31, 2016 | 69.08M |
September 30, 2016 | 96.28M |
June 30, 2016 | 70.74M |
March 31, 2016 | 59.29M |
December 31, 2015 | 71.44M |
September 30, 2015 | 72.05M |
June 30, 2015 | 82.46M |
March 31, 2015 | 71.12M |
December 31, 2014 | 44.75M |
September 30, 2014 | 38.72M |
June 30, 2014 | 31.62M |
March 31, 2014 | 13.89M |
December 31, 2013 | 10.97M |
September 30, 2013 | -24.22M |
June 30, 2013 | -33.59M |
March 31, 2013 | -34.84M |
December 31, 2012 | -9.931M |
September 30, 2012 | 39.80M |
June 30, 2012 | 43.16M |
March 31, 2012 | 72.48M |
December 31, 2011 | 65.90M |
Free Cash Flow Range, Past 5 Years
46.91M
Minimum
Sep 2019
274.39M
Maximum
Sep 2021
158.40M
Average
155.16M
Median
Free Cash Flow Benchmarks
Stryker Corp | 2.858B |
Boston Scientific Corp | 1.553B |
OraSure Technologies Inc | 134.40M |
Insulet Corp | 136.70M |
PROCEPT BioRobotics Corp | -126.17M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 15.76M |
Cash from Investing (Quarterly) | -53.96M |
Cash from Financing (Quarterly) | 358.68M |
Free Cash Flow Per Share (Quarterly) | 0.0037 |
Free Cash Flow to Equity (Quarterly) | 1.500B |
Free Cash Flow to Firm (Quarterly) | 5.676M |
Free Cash Flow Yield | 2.70% |